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Abstract
Background:  Anesthetic sensitivity is determined by the interaction of multiple genes. Hence, a
dissection of genetic contributors would be aided by precise and high throughput behavioral screens.
Traditionally, anesthetic phenotyping has addressed only induction of anesthesia, evaluated with dose-
response curves, while ignoring potentially important data on emergence from anesthesia.
Methods: We designed and built a controlled environment apparatus to permit rapid phenotyping of
twenty-four mice simultaneously. We used the loss of righting reflex to indicate anesthetic-induced
unconsciousness. After fitting the data to a sigmoidal dose-response curve with variable slope, we
calculated the MACLORR (EC50), the Hill coefficient, and the 95% confidence intervals bracketing these
values. Upon termination of the anesthetic, Emergence timeRR was determined and expressed as the mean
± standard error for each inhaled anesthetic.
Results: In agreement with several previously published reports we find that the MACLORR of halothane,
isoflurane, and sevoflurane in 8–12 week old C57BL/6J mice is 0.79% (95% confidence interval = 0.78 –
0.79%), 0.91% (95% confidence interval = 0.90 – 0.93%), and 1.96% (95% confidence interval = 1.94 –
1.97%), respectively. Hill coefficients for halothane, isoflurane, and sevoflurane are 24.7 (95% confidence
interval = 19.8 – 29.7%), 19.2 (95% confidence interval = 14.0 – 24.3%), and 33.1 (95% confidence interval
= 27.3 – 38.8%), respectively. After roughly 2.5 MACLORR • hr exposures, mice take 16.00 ± 1.07, 6.19 ±
0.32, and 2.15 ± 0.12 minutes to emerge from halothane, isoflurane, and sevoflurane, respectively.
Conclusion: This system enabled assessment of inhaled anesthetic responsiveness with a higher precision
than that previously reported. It is broadly adaptable for delivering an inhaled therapeutic (or toxin) to a
population while monitoring its vital signs, motor reflexes, and providing precise control over
environmental conditions. This system is also amenable to full automation. Data presented in this
manuscript prove the utility of the controlled environment chambers and should allow for subsequent
phenotyping of mice with targeted mutations that are expected to alter sensitivity to induction or
emergence from anesthesia.
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Background
The mechanisms that give rise to anesthetic-induced
unconsciousness have eluded understanding for more
than 150 years. Breakthroughs in circadian timekeeping
and sleep neurobiology have been made in recent years
using genetic approaches to unravel mutant phenotypes
in mice [1-4]. Genetic approaches offer an unparalleled
opportunity to elucidate complex biological problems
such as anesthetic action. One characteristic of successful
behavioral genetic endeavors has been the development
of rapid screens to identify mutant phenotypes [5]. A
common feature of these rapid screens is that they have
motor-dependent endpoints. Anesthetic-induced uncon-
sciousness is typically assessed using a loss of righting
reflex (LORR) assay. As with wheel running, this endpoint
depends upon movement and is amenable to full automa-
tion – another hallmark of successful forward genetic
screens [5]. The LORR assay has been used with mice to
identify genetic mutations that cause hypersensitivity
[6,7] or resistance [8] to various anesthetic agents.
In humans, general anesthesia is typically separated into
three phases: induction, maintenance, and emergence.
Animal studies of anesthetic sensitivity have failed to rec-
ognize these three phases, likely due to the inherent diffi-
culty in maintaining intravenous or intraperitoneal
steady-state levels of typical anesthetic agents such as pro-
pofol, etomidate, barbiturates, or ketamine. However,
with inhaled anesthetics, steady-state drug levels are easily
achieved. Multiple studies have attempted to decipher
molecular mechanisms crucial for induction of anesthesia
(reviewed in [9-12]), yet only rare reports characterize
mechanistic changes that occur upon emergence from
anesthesia [13-16]. Many clinical case reports suggest that
a variety of conditions can modulate emergence from
anesthesia with the most common finding being delayed
emergence in specific subsets of patients [17-21]. There is
a paucity of animal data investigating pharmacologic
treatments which might modify emergence [22,23]. To
date, there is only a single genetics study investigating par-
ticular phenotypes of mice that exhibit altered emergence
patterns following general anesthetics [24]. Greater
insight into the mechanisms through which anesthetics
induce unconsciousness as well as the mechanisms lead-
ing to its return are necessary to gain understanding of the
entire process of general anesthesia.
In this study we report the novel design and testing of high
throughput controlled environment chambers that will
allow detailed phenotypic characterization of murine sen-
sitivity to induction as well as emergence from general
anesthesia. This apparatus should facilitate both unbiased
forward genetic screens and putative anesthetic target
reverse genetic screens to evaluate molecular mechanisms
of inhaled anesthetic action. We have taken great care to
control for known confounders of anesthetic sensitivity
such as body temperature, circadian time, and anxiety of
mice in an unfamiliar testing environment. Using these
chambers we have studied the wild type sensitivity to
induction and emergence from 3 volatile anesthetics in
C57BL/6J male mice, aged 8–12 weeks.
Methods
Male C57BL/6J mice aged 8–12 week old weighing 23.6 ±
0.4 g (Jackson Laboratories, Bar Harbor, ME) were used in
this study, which was approved by the Animal Care and
Use Committee at the University of Pennsylvania. Mice
were maintained on a 12-hour light/dark cycle and had ad
libitum access to water and rodent chow before each day's
experiments. We built an open-circuit rodent anesthetiz-
ing system capable of simultaneously holding twenty-four
mice in isolated chambers provided with identical micro-
environments. Each of the 24 cylindrical chambers had an
internal diameter of 2.25 inches, a length of 3.875 inches,
and a volume of 250 ml. On each experimental day, inlet
gas pressure upstream of the parallel resistors was 2.5 PSI
(above atmospheric) which resulted in a uniform flow
108.0 ± 4.3 ml/min (figure 1 and tables 1, 2) as deter-
mined by a mass flowmeter (Omega Engineering, Stam-
ford, CT). Groups of 24 mice were habituated to the Loss
of Righting Chambers for two hours each day on four suc-
cessive days. During habituation, all mice breathed 100%
oxygen. Carbon dioxide levels were measured during
habituation sessions in the individual chamber exhaust
with a Datex Capnomatic II gas analyzer (Helsinki, Fin-
land). Temperature studies demonstrated that a constant
body temperature could be maintained by immersing the
entire anesthetizing apparatus in a water bath (table 3).
Submersion also allowed a daily gas leak test in the cham-
bers and associated tubing. Induction of general anesthe-
sia was accomplished with Drager model 19.1 isoflurane,
halothane, or sevoflurane vaporizers using eight to ten
stepwise incremental increases in the concentration of
anesthetic gas in oxygen. Initial concentrations of volatile
anesthetic gases were halothane 0.62% ± 0.02%, isoflu-
rane 0.67% ± 0.06%, and sevoflurane 1.56% ± 0.04%.
After 15 minutes at each concentration to allow equilibra-
tion of the mouse with the anesthetic vapors in the cham-
ber, the concentration of volatile anesthetic was increased
by 5 ± 1% of the preceding value. Peak concentrations of
volatile anesthetic gases were halothane 0.93% ± 0.01%,
isoflurane 1.07% ± 0.07%, and sevoflurane 2.22% ±
0.01%. Anesthetic gas concentration was determined in
real time to two decimal point accuracy with three inde-
pendent samples analyzed in the last two minutes of each
15-minute interval on a Riken FI-21 refractometer (AM
Bickford, Wales Center, NY) in 100% oxygen carrier gas
mode. Pilot studies of gas flow indicated that each of the
twenty-four chambers reached equilibrium within the
first 6 minutes, leaving 9 minutes for the average 25 gBMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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mouse with a minute ventilation of 30 ml/min and a car-
diac output of 12–20 ml/min [25,26] to equilibrate in the
chamber. At the end of each fifteen-minute interval, the
cylindrical chambers were rotated 180 degrees. A mouse
was considered to have lost the righting reflex if it was
unable to turn itself prone onto all four of its feet in the
ensuing two minutes. After the last of the twenty-four
mice had lost its righting reflex, volatile anesthetic con-
centration was increased one additional time prior to
measurements of emergence timeRR. With all mice in the
supine position, the anesthetic vapors were shut off (time
= 0 seconds) and the duration of time that elapsed until
each mouse regained its righting reflex by turning prone
onto all four feet was recorded. The total anesthetic dose,
defined as the integral of anesthetic gas concentration
multiplied by time at that concentration (15 minutes)
divided by the MACLORR for each agent as determined (see
text below and figure 3), was defined as the MACLORR • hr
and was recorded. After determining that mouse body
temperature was held within 0.6°C of baseline in a pilot
group of animals when the last mouse had lost its righting
reflex (rectal temperature probe, Physitemp Clifton, NJ),
rectal temperature was verified in each mouse once the
last animal had emerged from anesthesia. All anesthetic
gases were actively scavenged with wall suction. A room
air pop-off valve maintained the twenty-four mouse anes-
thetizing chambers at 1 atmosphere.
Statistical analysis
To obtain MACLORR and Hill slope constants, plots of the
log of the volatile anesthetic gas concentration versus
%population having lost the righting reflex were gener-
ated and fit with a non-linear dose-response curve with a
variable slope using Prism 4.0 (GraphPad Software, Inc.,
San Diego, CA). In order to minimize the number of ani-
mals used in the study and to confirm the reproducibility
of the data generated, a population of twenty-four mice
was exposed to the same anesthetic four times. Mice had
a minimum of 24 and a maximum of 72 hours between
anesthetic exposures. MACLORR and Hill slope constants
are reported as mean of four independent trials with 95%
confidence limits. Emergence timeRR  data generated
immediately following each anesthetic exposure is
reported as a mean ± standard error.
Results
Prior to putting mice in the modular anesthetizing cham-
bers, we verified the parallel circuit design by confirming
that each of the 24 chambers received equivalent gas flow,
Tables 1 and 2. By placing an anesthetic vaporizer
upstream of the parallel branching, identical concentra-
tions of volatile anesthetics were delivered to each of the
24 chambers. The anesthetizing circuit was an open
design predicted to have laminar flow based upon a calcu-
lated Reynolds number of 2.8. With an average of 108 ml/
Schematic Illustration of controlled environment chambers Figure 1
Schematic Illustration of controlled environment chambers. For the purposes of this diagram only six modules depict-
ing six mice are shown. For actual experiments, twenty-four controlled environment chambers were arrayed in parallel as 
shown above. Note that the limit for this design is based only on space and vaporizer performance. Recently capacity was 
increased to thirty chambers, which still exhibited identical gas flows thanks to the effects of each high resistance element 
placed upstream of each individual chamber.B
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Table 2: Flow data (percent total flow) as a function of 4 different input pressures.
Input Pressure Setting (PSI) A1 A2 A3 A4 A5 A6 B1 B2 B3 B4 B5 B6 C1 C2 C3 C4 C5 C6 D1 D2 D3 D4 D5 D6
2.0 4.25 4.15 3.77 3.72 3.82 4.25 4.25 4.254 . 3 03 . 8 24 . 3 04 . 2 54 . 2 04 . 2 54 . 3 04 . 3 04 . 2 04 . 2 54 . 3 04 . 3 04 . 3 04 . 2 54 . 0 14 . 2 0
2.5 4.26 4.22 3.84 3.80 3.87 4.26 4.26 4.264 . 3 43 . 8 44 . 3 04 . 2 64 . 2 24 . 2 24 . 2 64 . 2 64 . 1 84 . 1 84 . 2 64 . 2 64 . 2 64 . 2 23 . 9 54 . 1 8
5.0 4.21 4.16 3.78 3.75 3.85 4.26 4.21 4.214 . 2 93 . 8 34 . 2 64 . 2 64 . 2 14 . 2 64 . 2 94 . 3 14 . 2 14 . 2 64 . 2 94 . 2 94 . 2 94 . 2 94 . 0 14 . 2 4
7.5 4.23 4.17 3.82 3.78 3.88 4.25 4.25 4.254 . 3 13 . 8 64 . 2 94 . 2 74 . 2 34 . 2 54 . 2 74 . 2 74 . 1 94 . 2 34 . 2 74 . 2 94 . 2 74 . 2 53 . 9 54 . 2 1
%Avg 4.24 4.18 3.80 3.76 3.86 4.26 4.24 4.24 4.31 3.83 4.29 4.26 4.22 4.25 4.28 4.29 4.20 4.23 4.28 4.28 4.28 4.25 3.98 4.21
In this table, data from Table 1 have been transformed and are expressed as a percentage of total flow in each of the 24 chambers. The average flow per chamber independent of input pressure is 
displayed in the last row. Each of the individual 24 chambers was found to receive 4.17 ± 0.17 % of the total flow (mean ± standard deviation)
Table 1: Flow data (ml/min) as a function of 4 different input pressures
Input Pressure Setting (PSI) A1 A2 A3 A4 A5 A6 B1 B2 B3 B4 B5 B6 C1 C2 C3 C4 C5 C6 D1 D2 D3 D4 D5 D6
2 . 0 8 88 67 87 77 98 88 88 88 97 98 98 88 78 88 98 98 78 88 98 98 98 88 38 7
2.5 110 109 99 98 100 110 110 110 112 99 111 110 109 109 110 110 108 108 110 110 110 109 102 108
5.0 165 163 148 147 151 167 165 165 168 150 167 167 165 167 168 169 165 167 168 168 168 168 157 166
7.5 216 213 195 193 198 217 217 217 220 197 219 218 216 217 218 218 214 216 218 219 218 217 202 215BMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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min fresh gas flow applied to each chamber, expired CO2
was measured from each mouse by sampling individual
chamber outflow gases. The maximal CO2 measurement
ever obtained was 14 torr (1.8%) upon the first entry of a
mouse into its chamber. The average CO2 outflow meas-
urement was 8.4 ± 0.5 torr on the first day of habituation.
Over the course of 4 successive days, CO2 levels in cham-
ber egress gas dropped from 8.4 ± 0.5 torr to 4.8 ± 0.1 torr.
This suggests that CO2 production decreased as the mice
become accustomed to the confined chamber, figure 1.
When placed in the chambers and exposed to 100 ml/min
fresh gas flow, unanesthetized mice drop their core body
temperature from 37.3 ± 0.1°C to 36.6 ± 0.1°C. Without
active heat transfer, mice exposed to 1.25% isoflurane in
dehumidified oxygen for two hours were found to cool to
25.4 ± 0.4°C, which approaches room temperature (table
3). Since sensitivity to anesthesia is significantly modu-
lated by temperature, we designed a means of conductive
heat transfer by placing the chambers in a heated water
bath. With the water bath set to 37°C, we were able main-
tain mice at 36.6 ± 0.1°C, eliminating hypothermia as a
confounder regardless of the duration of the anesthetic
exposure.
Having optimized the anesthetizing chambers with
appropriate environmental controls (temperature,
humidity, and inhaled gas composition) we subjected
mice to MACLORR  determinations as described in the
methods. Figure 2 shows the population response for wild
type C57BL/6J mice exposed to halothane, isoflurane, and
sevoflurane. Best-fit parameters for data are displayed in
figure 3. Emergence from anesthesia as defined by recov-
ery of the righting reflex is shown in figure 4. Cumulative
anesthetic doses prior to emergence were 2.4 ± 0.1, 2.8 ±
0.1, and 2.7 ± 0.3 MACLORR • hrs for halothane, isoflu-
rane, and sevoflurane respectively.
Discussion
We have constructed and validated modular chambers to
conduct high throughput screens of anesthetic-induced
loss of righting reflex and its subsequent return. Using
Table 3: Anesthetic Effects upon Mouse Body Temperature
Condition Average Standard Error Number of Mice
Baseline Temperature
Prior to placement in chambers (FGF = 0)
No anesthetic exposure
No active warming
37.3 0.1 109
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
No anesthetic exposure
No active warming
36.6 0.1 24
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
Anesthetic = Isoflurane 1.25%
No active warming
25.4 2.3 30
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
Anesthetic = Isoflurane 1.25%
Apparatus in water bath set to 33°C
33.0 0.2 10
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
Anesthetic = Isoflurane 1.25%
Apparatus in water bath set to 36°C
36.2 0.2 10
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
Anesthetic = Isoflurane 1.25%
Apparatus in water bath set to 40°C
39.8 0.2 11
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
No Anesthetic Exposure
Apparatus in water bath set to 37°C
36.5 0.1 24
Temperature after 2 hr exposure to
FGF = 100 ml/min oxygen
Anesthetic = Isoflurane 1.25%
Apparatus in water bath set to 37°C
36.6 0.1 16
Temperature measurements at baseline and following 2 hours of exposure to 100 ml/min oxygen fresh gas flow (FGF) in controlled environment 
chambers (250 ml volume apiece) in the presence or absence of 1.25% isoflurane and varying degrees of warming obtained by submerging 
controlled environment chambers in a water bath. Room temperature varied between 20–22°C.BMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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inhaled anesthetic gases, we studied induction and emer-
gence from anesthesia by measuring the following param-
eters: 1) MACLORR, defined as the minimum alveolar
concentration at which 50% of the test population has
lost its righting reflex; 2) Hill slope which evaluates the
steepness of the transition from wakefulness to general
anesthesia for the test population; and 3) emergence
timeRR, defined as the duration of time before a popula-
tion regains its righting reflex. Whereas most studies of
anesthetic sensitivity evaluate MAC (MACimmobility),
defined as the minimum alveolar concentration required
to prevent movement in 50% of a population in response
to a noxious stimulus such as a tail pinch [27-29], we are
primarily interested in the hypnotic component of
anesthesia. As outlined by Mashour and colleagues, the
hypnotic component of anesthesia is most precisely
defined as a lack of "perceptive awareness" [10] and
should therefore be evaluated following a non-noxious
stimulus such as turning an animal prone to supine to
examine its righting reflex. The righting reflex provides
one behavioral measure commonly used to assess hypno-
sis in rodents. However, when used alone this assay could
yield false positive interpretations of behavioral state. If
one administered a muscle relaxant by itself, treated mice
would exhibit LORR while remaining fully aware. Hence,
for a formal genetic analysis, MACLORR and emergence
timeRR data should be combined with a second index of
behavioral state such as EEG-based analyses. An EEG-
based secondary screen would reveal cortical signatures of
anesthetic action that should compliment the righting
reflex's brainstem signatures [30].
Our reported values for MACLORR are in good agreement
with values obtained by Homanics and colleagues using a
similar best-fit approach for sigmoidal dose response data
[31]. The small difference in MACLORR for halothane (our
determination is 13% greater than theirs) is easily
accounted by the different genetic background of their
mice which could influence anesthetic sensitivity by as
much as 40% [32]. Our best fit values for Hill coefficients
are within the expected range for volatile anesthetics of
20–30 [33]. Lastly, the "goodness of fit" for our behavio-
ral data as measured by r2 obtained with our apparatus is
high relative to the literature (figure 3). We attribute these
high best-fit values to reductions in experimental error
both due to the uniform delivery of experimental condi-
tions among all mice in our controlled environment anes-
thetizing chambers on a given day and to the
reproducibility of conditions achieved with our chambers
on different days.
MACLORR dose-response curves Figure 2
MACLORR dose-response curves. MACLORR Dose-Response Curves displayed on a standard semi-log plot demonstrating 
responses of a population of 24 wild type C57BL/6J male mice aged 8–12 weeks to increasing doses of halothane (red circles), 
isoflurane (purple squares), and sevoflurane (yellow triangles).BMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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Several other groups have sought to determine MACLORR
in mice. While attempting to assess the hypnotic compo-
nent of anesthesia in mice with mutations in the AMPA
receptor, GluR2 [6], and also in the nicotinic acetylcho-
line receptor subunit, beta 2 [34], lower values for
MACLORR  were reported. Joo and colleagues quoted
MACLORR for isoflurane at 0.57 ± 0.16%, and sevoflurane
at 1.16 ± 0.19% in their wild type controls. Their range for
halothane of 0.67 ± 0.20% was similar to ours. Also in
agreement with Joo's MACLORR findings are those of Flood
and colleagues [34] who found MACLORR of isoflurane in
inbred 129 mice was 0.56 ± 0.10% and MACLORR of isoflu-
rane in C57BL/6J mice was 0.63 ± 0.20%. One major
methodological difference could account for the discrep-
ancy in MACLORR. Both Joo and Flood used a bracketing
measurement, which averages the highest anesthetic con-
Statistical analysis of MACLORR dose-response curves Figure 3
Statistical analysis of MACLORR dose-response curves. Data were fit with a logistic equation of the form: Y = XHill slope/
[XHill slope + MACLORR
Hill slope] where Y is the fraction of the population that has lost its righting reflex, X is the anesthetic con-
centration, MACLORR is the dose at which 50% of the population has lost its righting reflex, and Hill slope is a constant that rep-
resents the steepness of the dose-response curve. The accompanying table reports best fit values for MACLORR and Hill slope 
for each anesthetic gas along with the 95% confidence intervals surrounding the fit.BMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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centration at which mice still retain the righting reflex
with the lowest anesthetic concentration at which mice
have lost the righting reflex to estimate MACLORR. If the
incremental anesthetic concentration step size is large,
systematic error in MACLORR  determination can't be
avoided, as Hill slopes for anesthetic drugs are notori-
ously steep.
In creating our modular, high throughput, controlled
environment, anesthetizing chambers, we were con-
fronted with several significant design problems. The first
revolved around the high metabolic rate of mice. With a
minute ventilation of approximately 30 ml/min [26] and
a carbon dioxide production rate, VCO2, of 1.3 ml/min at
rest [35,36], any arrangement of mouse chambers in series
would lead to rebreathing at low fresh gas flows, evapora-
tive and convective heat loss at high fresh gas flows, and
heterogeneous conditions for mice at different positions
relative to the fresh gas inlet. Thus, it became clear that the
mice must be arrayed in parallel. Even with each animal
having its own fresh gas source, carbon dioxide handling
issues remained. We reasoned that during initial exposure
to the chambers, mice would experience a mild restraint
stress caused by confinement in the 250 ml tubes (figure
1). This would increase carbon dioxide production. With
repeated exposure during 4 daily habituation sessions,
measured expired carbon dioxide levels from all mice
decreased, consistent with a decrease in VCO2 production
during habituation. Further, we reasoned that at 100 ml/
min fresh gas flow in each chamber, convective flow
should vastly exceed the capacity of CO2-rich expired
gases to back diffuse into the inspired fresh gas flow, thus
reducing rebreathing. Nonetheless, even assuming the
worst-case scenario of perfect mixing in each chamber,
and a maximal murine VCO2 of 100 ml·kg-1·min-1, the
theoretical upper limit for inspired CO2 in our chambers
for a 25 g mouse receiving fresh gas flow at 100 ml/min is
2.5%. Our data suggests that the mice only produce
enough CO2 to occupy up to 1.1% on initial entry in the
chambers on day one of habituation and that this declines
to 0.6% on the last day of habituation. It should be noted
that these values represent the maximum theoretical
Emergence TimesRR for Halothane, Isoflurane, and Sevoflurane Figure 4
Emergence TimesRR for Halothane, Isoflurane, and Sevoflurane. Following the stepwise increases in anesthetic gas 
concentration, anesthetic gases were abruptly discontinued after the last mouse had lost its righting reflex. The duration of 
time that elapsed until all mice regained their righting reflexes was recorded. Data are displayed as the mean ± standard error. 
The cumulative anesthetic doses were 2.4 ± 0.1, 2.8 ± 0.1, and 2.7 ± 0.3 MACLORR • hrs for halothane (red), isoflurane (purple), 
and sevoflurane (yellow) respectively.BMC Anesthesiology 2006, 6:13 http://www.biomedcentral.com/1471-2253/6/13
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upper limit for inspired CO2. Actual inspired CO2 concen-
trations will be much lower as net fresh gas flow will be
laminar across any given chamber and convective flow
should predominate.
Another challenge posed by this open circuit setup of our
chambers is the enormous potential for convective heat
loss in anesthetized mice. Unanesthetized mice, capable
of normal thermoregulation, experienced only a small
decline in body temperature (0.6°C), which was not sig-
nificantly different if the chambers were submerged in a
37°C water bath. While the awake mouse maintains its
core body temperature through vasoconstriction, anes-
thetic gases inhibit central and peripheral thermoregula-
tion [37]. Therefore, in the anesthetized mouse, heat
transfer to the chambers submerged in the water bath is
essential to maintain normothermia.
Whereas we have chosen to use these controlled environ-
ment chambers to deliver an inhaled anesthetic and meas-
ure hypnotic responses of wild type mice, this system
could easily be used to deliver any inhaled therapeutic or
toxin in any setting where precise control over the testing
environment is necessary. With our parallel open circuit
design, gas flow is evenly divided between the 24 individ-
ual chambers. However, there is no reason why the
number of chambers is limited to 24. We have recently
increased the capacity to 30 chambers while still main-
taining identical individual microenvironments. Gas
composition, humidity, and test subjects' temperatures
can be easily regulated. Moreover, by implanting telemet-
ric transmitters in mice, it is possible to stream other phys-
iologic data from each of the 24 pods to corresponding
detectors. In this way, vital signs such as blood pressure,
heart rate, respiratory rate, core body temperature, as well
as electroencephalographic and electromyographic sig-
nals that may be altered by the delivery of an inhaled ther-
apeutic can be continuously monitored. We believe that
development of apparatus along these lines will enhance
our ability to rapidly dissect the pharmacogenetics of vol-
atile drug action.
Conclusion
This study lays the foundation for rapid screening of genes
that alter anesthetic sensitivity in mice by establishing a
reproducible, high throughput system for the analysis of
anesthetic-induced loss and subsequent recovery of the
righting reflex, a commonly used behavioral correlate of
anesthetic-induced unconsciousness in rodents.
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